In This Section      
Print This Page

Current News Releases

Current News Releases

Released: July 20, 2018

Study advances search for safer drugs for human heart failure

A drug currently in clinical trials for treating symptoms of Parkinson’s disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

Released: July 18, 2018

An analysis of more than 1,000 people with and without psychiatric disorders has shown that nitrates—chemicals used to cure meats such as beef jerky, salami, hot dogs and other processed meat snacks—may contribute to mania, an abnormal mood state. Mania is characterized by hyperactivity, euphoria and insomnia.

Released: July 17, 2018

Less education and unaccompanied medical visits linked to lack of formal diagnosis or awareness of diagnosis

A Johns Hopkins Medicine analysis of information gathered for an ongoing and federally sponsored study of aging and disability adds to evidence that a substantial majority of older adults with probable dementia in the United States have never been professionally diagnosed or are unaware they have been.

Released: July 12, 2018

In a “proof of concept” study, scientists at Johns Hopkins Medicine say they have successfully delivered nano-size packets of genetic code called microRNAs to treat human brain tumors implanted in mice. The contents of the super-small containers were designed to target cancer stem cells, a kind of cellular “seed” that produces countless progeny and is a relentless barrier to ridding the brain of malignant cells.

Released: July 11, 2018

The gains in insurance coverage with the Patient Protection and Affordable Care Act (ACA) have already translated into improved health for young women with gynecologic cancers, who are getting diagnosed at earlier stages of their disease because of ACA benefits. That’s the conclusion of a new study by researchers at Johns Hopkins Medicine, who looked at nationwide trends in gynecologic cancer diagnosis in a large population of women before and after the ACA’s implementation in 2010.

Released: July 10, 2018

Johns Hopkins researchers have found that the cellular “garbage disposal,” known to scientists as proteasomes, may not only be responsible for the removal of cellular waste, but actually work on some of the most important proteins to neuronal development.

Released: July 9, 2018

Small Study Based on Subjective Interviews Explores Decision-Making Process in Life-and-Death Emergencies

In a small study based on conversations with 20 hospital-based surgeons, Johns Hopkins researchers say they found that most report feeling pressure to operate under severe emergency situations, even when they believe the patients would not benefit.
Released: July 2, 2018

Researchers at Johns Hopkins have added to evidence that rising and chronic inflammation as measured by a biomarker in the blood in middle and late age are linked to visible structural changes in the brains of people with poor cognition and dementia.
Released: July 2, 2018

Johns Hopkins researchers say they have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson’s disease itself — as well as its symptoms — in mice
Released: July 2, 2018

New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center.
Released: June 29, 2018

Recognized for commitment to nursing excellence for fourth time

Baltimore (June 29, 2018) — The Johns Hopkins Hospital has once again achieved Magnet designation in recognition of its nursing excellence. The American Nurses Credentialing Center’s Magnet Recognition Program is the highest national credential for professionalnursing practice. Only about 7.5 percent of U.S. health care organizations have achieved Magnet recognition.
Released: June 26, 2018

BALTIMORE (June 26, 2018) – Johns Hopkins Children’s Center ranked #8 in the nation on U.S. News & World Report’s 2018-19 Best Children’s Hospitals Honor Roll. Johns Hopkins Children’s Center has the distinction of being the only children’s hospital integrated with an adult facility to make the Honor Roll this year.
Released: June 25, 2018

Proof-of-concept study in mice and rats focuses on new target for opioid drugs

A team of researchers at Johns Hopkins have found that activating nerve cell receptors along two chemical pathways — one that has previously been linked to how the brain senses “itch” — may improve pain relief when combined with conventional ways to blunt pain using opioid drugs, such as morphine. 
Released: June 25, 2018

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer. The study suggested a genetic subset of prostate cancer may benefit from this form of immunotherapy.
Released: June 22, 2018

A gathering of clinicians, researchers, advocates and patients will share information and shed light on the need for improved focus and funding for metastatic and stage IV breast cancer.

The fifth annual Metastatic Breast Cancer Conference invites participants from around the world to discuss ongoing research, showcase new ideas from young scientists, and bring together advocates who are working with metastatic breast cancer patients. This year, the conference will be hosted by the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins School of Medicine in Baltimore on Nov. 15 and 16.
Released: June 19, 2018

Reviewing medical information gathered on more than 6,000 adults over a 10-year period, Johns Hopkins researchers have found that lower than normal blood levels of vitamin D were linked to increased risk of early signs of interstitial lung disease (ILD).
Released: June 18, 2018

J. Alex Haller Jr., M.D., a trailblazing pioneer in pediatric surgery, pediatric trauma treatment and biomedical ethics who transformed the practice of pediatric care at Johns Hopkins and throughout the nation, died on June 13 in Glencoe, Maryland. He was 91.
Released: June 14, 2018

Josie the dog is first to complete clinical trial for deadly dog cancer

At 12 years old (84 in dog years), the Robertson family’s beloved terrier mix, Josie, had been through it all. She had a tattoo of the phone number from the “last chance” shelter where her family rescued her, she had had both knees repaired, was injured when a bigger dog attacked her, and was losing her sight and hearing with age — all before she was diagnosed with one of the deadliest cancers known to dogkind, hemangiosarcoma.
Released: June 14, 2018

Johns Hopkins scientists advance knowledge of prurigo nodularis

An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis (PN). Such studies collect information on a whole subset of people at once and at a particular point in time.